EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -0.2374
March 31, 2026 -0.3259
December 31, 2025 -0.2518
September 30, 2025 -0.3409
June 30, 2025 -0.3753
March 31, 2025 -0.3616
December 31, 2024 -0.3329
September 30, 2024 -0.3601
June 30, 2024 -0.3936
March 31, 2024 -0.3559
December 31, 2023 -0.3619
September 30, 2023 -0.3909
June 30, 2023 -0.4282
March 31, 2023 -0.4221
December 31, 2022 -0.3821
Date Value
September 30, 2022 -0.3811
June 30, 2022 -0.3956
March 31, 2022 -0.43
December 31, 2021 -0.355
September 30, 2021 -0.2793
June 30, 2021 -0.3596
March 31, 2021 -0.3537
December 31, 2020 -0.2741
September 30, 2020 -0.1082
June 30, 2020 -0.3362
March 31, 2020 -0.2022
December 31, 2019 -0.1318
September 30, 2019 -0.1224
June 30, 2019 -0.1573
March 31, 2019 -0.173

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 0.5293
AngioDynamics, Inc. -0.1689
Alphatec Holdings, Inc. -0.1647
AtriCure, Inc. 0.1832
Baxter International, Inc. 0.2432